# COGT (Cogent Biosciences, Inc.) - SEC EDGAR Financial Statements

> Cogent Biosciences, Inc. reported $832.1M in total assets and a net loss of $407.7M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/COGT
- Markdown: https://convexityos.com/fundamentals/COGT.md
- SEC CIK: 0001622229
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001622229&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$422.9M | Operating profit |
| Net Income | FY 2025 | -$407.7M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.35 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$325.8M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $791.1M | Total debt: $244.2M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | $7.87M | $22.50M | $9.73M | $8.36M |
| Research & Development | $269.8M | $232.7M | $173.8M | $121.6M | $55.91M | $25.74M | $43.71M | $38.28M | $29.83M |
| **Operating Income** | -$333.4M | -$275.9M | -$208.1M | -$147.8M | -$75.55M | -$82.20M | -$32.18M | -$36.01M | -$26.15M |
| **EBITDA** | -$330.8M | -$273.4M | -$205.8M | -$147.0M | -$75.40M | -$81.48M | -$30.89M | -$34.68M | -$24.98M |
| Interest Income | $14.69M | $18.09M | $13.08M | $3.99M | $467K | $144K | $267K | $1.15M | $386K |
| Interest Expense | $3.06M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$328.9M | -$255.9M | -$192.4M | -$140.2M | -$72.27M | -$74.81M | -$31.83M | -$34.53M | -$25.49M |
| Basic EPS | -$2.16 | -$1.94 | -$1.94 | -$1.73 | -$1.87 | -$16.17 | -$4.18 | -$1.39 | -$2.51 |
| **Diluted EPS** | -$2.16 | -$1.94 | -$1.94 | -$1.73 | -$1.87 | -$16.17 | -$4.18 | -$1.39 | -$2.51 |
| Basic Shares Outstanding | 128.9M | 103.9M | 79.7M | 58.7M | 38.7M | 11.1M | 7.6M | 24.9M | 10.2M |
| Diluted Shares Outstanding | 128.9M | 103.9M | 79.7M | 58.7M | 38.7M | 11.1M | 7.6M | 24.9M | 10.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $75.10M | $70.81M | $75.36M | $75.56M | $68.99M | $62.20M | $63.03M | $62.05M |
| **Operating Income** | -$117.2M | -$102.6M | -$103.6M | -$99.49M | -$83.36M | -$75.58M | -$74.93M | -$73.73M |
| **EBITDA** | -$116.6M | -$101.9M | -$103.0M | -$98.83M | -$82.71M | -$74.93M | -$74.29M | -$73.06M |
| Interest Income | $7.05M | $7.46M | $7.61M | $5.48M | $3.89M | $2.37M | $2.95M | $3.86M |
| Interest Expense | $1.24M | $1.22M | $1.21M | -- | $1.46M | $314K | -- | -- |
| **Net Income** | -$111.4M | -$96.41M | -$97.35M | -$102.5M | -$80.93M | -$73.53M | -$71.99M | -$67.93M |
| Basic EPS | -$0.59 | -$0.52 | -$0.53 | -- | -$0.50 | -$0.53 | -$0.52 | -- |
| **Diluted EPS** | -$0.59 | -$0.52 | -$0.53 | -- | -$0.50 | -$0.53 | -$0.52 | -- |
| Basic Shares Outstanding | 173.1M | 171.0M | 162.2M | -- | 137.6M | 114.5M | 113.3M | -- |
| Diluted Shares Outstanding | 173.1M | 171.0M | 162.2M | -- | 137.6M | 114.5M | 113.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $312.0M | $98.17M | $53.23M | $139.9M | $219.7M | $242.2M | $37.42M | $55.67M | $28.27M |
| Short-Term Investments | $588.8M | $188.9M | $212.5M | $119.4M | $0 | -- | -- | -- | $12.69M |
| **Cash & Short-Term Investments** | $900.8M | $287.1M | $265.7M | $259.3M | $219.7M | $242.2M | $37.42M | $55.67M | $40.96M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $2.00M | $1.67M | $830K |
| **Total Current Assets** | $910.4M | $296.5M | $270.8M | $265.0M | $222.6M | $244.9M | $40.59M | $81.00M | $42.38M |
| Property, Plant & Equipment, Net | $5.46M | $6.47M | $8.34M | $7.78M | $1.71M | $134K | $1.86M | $3.25M | $4.11M |
| Long-Term Investments | -- | -- | $7.46M | $0 | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $3.30M | $4.86M | $4.86M | $4.75M | $3.73M | -- | $427K | $419K | -- |
| **Total Non-Current Assets** | $27.25M | $31.43M | $42.67M | $35.84M | $9.46M | $6.00M | $8.83M | $4.92M | $6.74M |
| **Total Assets** | $937.6M | $327.9M | $313.4M | $300.8M | $232.1M | $250.9M | $49.42M | $85.93M | $49.12M |
| Accounts Payable | $9.50M | $12.01M | $10.65M | $5.84M | $3.48M | $732K | $3.18M | $1.52M | $1.35M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $1.31M | $17.95M | $6.89M |
| **Total Current Liabilities** | $63.95M | $55.71M | $38.17M | $26.85M | $17.08M | $13.09M | $13.25M | $24.95M | $11.19M |
| Long-Term Debt | $222.9M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $8.71M |
| Other Non-Current Liabilities | $33K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $237.3M | $15.90M | $17.47M | $18.23M | $831K | $3.15M | $4.41M | $748K | $9.62M |
| **Total Liabilities** | $301.2M | $71.61M | $55.63M | $45.08M | $17.91M | $16.25M | $17.66M | $25.69M | $20.81M |
| **Total Debt (incl. Leases)** | $238.8M | $17.47M | $18.85M | $19.65M | $3.15M | $5.21M | $6.03M | -- | -- |
| Common Stock | $161K | $110K | $86K | $70K | $44K | $32K | $8.0K | $30K | $10K |
| Retained Earnings | -$1.19B | -$859.5M | -$603.6M | -$411.2M | -$271.0M | -$198.7M | -$123.9M | -$92.06M | -$51.34M |
| Accumulated Other Comp. Income | $355K | $447K | $246K | -$104K | -- | -- | -- | -$12K | -$16K |
| **Total Stockholders' Equity** | $636.4M | $256.3M | $257.8M | $255.7M | $214.2M | $234.7M | $31.76M | $60.23M | -$48.85M |
| Total Equity | $636.4M | $256.3M | $257.8M | $255.7M | $214.2M | $234.7M | $31.76M | $60.23M | -$48.85M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $217.5M | $181.2M | $241.2M | $312.0M | $125.3M | $127.6M | $126.0M | $98.17M |
| Short-Term Investments | $573.7M | $611.1M | $625.2M | $588.8M | $265.6M | $110.2M | $119.7M | $188.9M |
| **Cash & Short-Term Investments** | $791.1M | $792.3M | $866.4M | $900.8M | $390.9M | $237.8M | $245.7M | $287.1M |
| **Total Current Assets** | $803.6M | $804.8M | $877.8M | $910.4M | $397.2M | $245.0M | $252.9M | $296.5M |
| Property, Plant & Equipment, Net | $4.31M | $4.78M | $5.30M | $5.46M | $5.27M | $5.85M | $6.45M | $6.47M |
| Other Non-Current Assets | $1.91M | $1.94M | $1.94M | $3.30M | $4.49M | $4.86M | $4.86M | $4.86M |
| **Total Non-Current Assets** | $28.56M | $29.73M | $25.20M | $27.25M | $28.69M | $29.81M | $30.91M | $31.43M |
| **Total Assets** | $832.1M | $834.5M | $903.0M | $937.6M | $425.9M | $274.8M | $283.8M | $327.9M |
| Accounts Payable | $5.94M | $7.49M | $13.74M | $9.50M | $16.03M | $16.62M | $14.15M | $12.01M |
| **Total Current Liabilities** | $73.12M | $59.30M | $57.98M | $63.95M | $62.25M | $58.42M | $49.32M | $55.71M |
| Long-Term Debt | $223.7M | $223.5M | $223.2M | $222.9M | $44.25M | $43.95M | -- | $0 |
| Other Non-Current Liabilities | $123K | $90K | $62K | $33K | $2.37M | $2.36M | $5.0K | $0 |
| **Total Non-Current Liabilities** | $242.8M | $242.9M | $237.3M | $237.3M | $61.22M | $61.36M | $15.48M | $15.90M |
| **Total Liabilities** | $315.9M | $302.2M | $295.3M | $301.2M | $123.5M | $119.8M | $64.80M | $71.61M |
| **Total Debt (incl. Leases)** | $244.2M | $244.3M | $238.7M | $238.8M | $60.56M | $60.66M | $17.09M | $17.47M |
| Common Stock | $174K | $171K | $171K | $161K | $141K | $114K | $114K | $110K |
| Retained Earnings | -$1.49B | -$1.38B | -$1.29B | -$1.19B | -$1.09B | -$1.00B | -$931.5M | -$859.5M |
| Accumulated Other Comp. Income | -$717K | -$770K | -$415K | $355K | $208K | $13K | $164K | $447K |
| **Total Stockholders' Equity** | $516.3M | $532.4M | $607.7M | $636.4M | $302.5M | $155.0M | $219.0M | $256.3M |
| Total Equity | $516.3M | $532.4M | $607.7M | $636.4M | $302.5M | $155.0M | $219.0M | $256.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$328.9M | -$255.9M | -$192.4M | -$140.2M | -$72.27M | -$74.81M | -$31.83M | -$34.53M | -$25.49M |
| Depreciation & Amortization | $2.60M | $2.50M | $2.30M | $800K | $147K | $720K | $1.29M | $1.32M | $1.17M |
| Stock-Based Compensation | $46.08M | $39.74M | $30.62M | $18.37M | $11.69M | $6.02M | $3.24M | $3.09M | $1.34M |
| Change in Receivables | -- | -- | -- | -- | -- | $2.00M | -$332K | -$838K | $98K |
| Change in Payables | -$2.51M | $1.36M | $4.81M | $2.36M | $2.75M | -$2.45M | $1.66M | $367K | -$31K |
| **Operating Cash Flow** | -$264.4M | -$207.8M | -$153.6M | -$118.6M | -$58.76M | -$35.85M | -$41.51M | -$32.49M | -$25.84M |
| Capital Expenditure | -$1.55M | -$573K | -$2.80M | -$6.86M | -$1.72M | -- | -$33K | -$549K | -$912K |
| **Free Cash Flow** | -$266.0M | -$208.4M | -$156.4M | -$125.5M | -$60.48M | -- | -$41.55M | -$33.04M | -$26.75M |
| Purchases of Investments | -$687.2M | -$255.6M | -$348.8M | -$177.9M | $0 | -- | -- | -$47.68M | -$6.50M |
| **Investing Cash Flow** | -$399.5M | $38.28M | -$97.82M | -$124.7M | -$1.72M | $8.42M | $23.16M | -$10.53M | $13.59M |
| Common Stock Issued | -- | $0 | $161.8M | $0 | $0 | $25.00M | $108K | $609K | $60K |
| **Financing Cash Flow** | $878.2M | $214.5M | $163.5M | $163.6M | $37.98M | $232.2M | $108K | $70.35M | -$729K |
| **Net Change in Cash** | $214.3M | $44.94M | -$87.91M | -$79.80M | -$22.51M | $204.8M | -$18.25M | $27.33M | -$12.98M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$111.4M | -$96.41M | -$97.35M | -$102.5M | -$80.93M | -$73.53M | -$71.99M | -$67.93M |
| Depreciation & Amortization | $572K | $741K | $626K | $664K | $641K | $655K | $640K | $675K |
| Stock-Based Compensation | $16.87M | $17.11M | $16.91M | $15.75M | $10.60M | $9.72M | $10.01M | $9.98M |
| Change in Payables | -$1.55M | -$6.26M | $4.24M | -$6.53M | -$596K | $2.47M | $2.14M | -$3.05M |
| **Operating Cash Flow** | -$80.79M | -$77.27M | -$86.88M | -$79.11M | -$64.29M | -$54.54M | -$66.51M | -$60.58M |
| Capital Expenditure | -$108K | -$370K | -$449K | -$811K | -$65K | -$131K | -$547K | -$75K |
| **Free Cash Flow** | -$80.89M | -$77.64M | -$87.33M | -$79.92M | -$64.35M | -$54.67M | -$67.06M | -$60.65M |
| Purchases of Investments | -$74.07M | -$82.81M | -$133.8M | -$395.2M | -$224.1M | -$67.88M | $0 | -$12.72M |
| **Investing Cash Flow** | $37.31M | $14.28M | -$36.46M | -$322.8M | -$155.0M | $8.91M | $69.38M | $61.67M |
| **Financing Cash Flow** | $79.76M | $2.96M | $52.54M | $588.7M | $217.4M | $47.23M | $24.97M | $26K |
| **Net Change in Cash** | $36.29M | -$60.04M | -$70.80M | $186.8M | -$1.97M | $1.59M | $27.84M | $1.12M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -1044.3% | -143.0% | -369.9% | -312.8% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -950.4% | -141.5% | -354.8% | -304.9% |
| Return on Equity (ROE) | -51.7% | -99.8% | -74.6% | -54.8% | -33.7% | -31.9% | -100.2% | -57.3% | -- |
| Return on Assets (ROA) | -35.1% | -78.0% | -61.4% | -46.6% | -31.1% | -29.8% | -64.4% | -40.2% | -51.9% |
| Current Ratio | 14.23x | 5.32x | 7.09x | 9.87x | 13.04x | 18.70x | 3.06x | 3.25x | 3.79x |
| Quick Ratio | 14.08x | 5.15x | 6.96x | 9.66x | 12.86x | 18.50x | 2.98x | 2.30x | 3.73x |
| Debt to Equity | 0.38x | 0.07x | 0.07x | 0.08x | 0.01x | 0.02x | 0.19x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -65.0% | +131.1% | +16.4% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -79.0% | -70.8% | -58.3% | -51.7% | -97.3% | -183.2% | -123.1% | -99.8% |
| Return on Assets (ROA) | -49.0% | -45.2% | -39.2% | -35.1% | -69.1% | -103.4% | -95.0% | -78.0% |
| Current Ratio | 10.99x | 13.57x | 15.14x | 14.23x | 6.38x | 4.19x | 5.13x | 5.32x |
| Quick Ratio | 10.82x | 13.36x | 14.94x | 14.08x | 6.28x | 4.07x | 4.98x | 5.15x |
| Debt to Equity | 0.47x | 0.46x | 0.39x | 0.38x | 0.20x | 0.39x | 0.08x | 0.07x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
